Healthcare - Biotechnology - NASDAQ - GB
$ 0.662
3.28 %
$ 188 K
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-10.5 M
OPERATING CASH FLOW
-209 K
INVESTING CASH FLOW
8.52 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
TC Biopharm (Holdings) Plc
| Net Income | -5.91 M |
| Depreciation & Amortization | 633 K |
| Capital Expenditures | -110 K |
| Stock-Based Compensation | 444 K |
| Change in Working Capital | 1.54 M |
| Others | -6.39 M |
| Free Cash Flow | -10.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (5.9) | (1.3) | (13.6) | (5.5) | (6.1) |
| Depreciation & Amortization | 0.6 | 1.0 | 1.0 | 1.1 | 0.9 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.4 | 1.1 | 0 | 0.8 | 0.8 |
| Other Operating Activities | (7.3) | (15.3) | 7.6 | (1.6) | (2.7) |
| Change in Working Capital | 1.5 | (0.8) | (0.6) | 1.7 | 0.3 |
| Cash From Operations | (10.5) | (15.3) | (5.6) | (3.4) | (6.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.1) | (0.2) | 20 K | 34.9 K | (2.0) |
| Other Items | 98.4 K | 69.5 K | (0.1) | (0.2) | (0.2) |
| Cash From Investing Activities | (0.2) | (0.3) | (0.1) | (0.2) | (2.2) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (2.6) | 6.3 | (0.4) | 0.1 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.3 | 17.9 | 21.2 K | 53.3 K | 0 |
| Cash From Financing Activities | 8.5 | 18.7 | 6.5 | 3.4 | 3.3 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (2.3) | 3.2 | 0.8 | (0.2) | 1.0 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (10.7) | (15.5) | (5.6) | (3.5) | (8.8) |